Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2025-12-26 @ 1:58 AM
Study NCT ID:
NCT01030705
Status:
COMPLETED
Last Update Posted:
2011-09-29
First Post:
2009-12-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Common Sensing and Right Ventricular Automatic Capture (COGNATE)
Sponsor:
Boston Scientific Corporation
Organization:
Study Overview
Official Title:
Common Sensing and Right Ventricular Automatic Capture
Status:
COMPLETED
Status Verified Date:
2011-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COGNATE
Brief Summary:
This study will collect data on features for future pacemakers via an external non-implantable system.
Detailed Description:
COGNATE is an acute, confirmatory prospective, multi-center study designed to gather data on Brady and CRT-P indicated patients, with no restrictions on the type/brand of leads. This study will enroll up to 80 patients in up to 12 centers. Total duration of the study is expected to be 9 months.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: